Literatur
Schirmer JH, Aries PM, de Groot K, Hellmich B, Holle JU, Kneitz C et al (2017) S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden. Z Rheumatol 76(Suppl 3):77–104
Jayne DRW, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18(7):2180–2188
Walsh M, Casian A, Flossmann O, Westman K, Höglund P, Pusey C et al (2013) Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int 84(2):397–402
Hellmich B, Löffler C (2019) What are the indications for rescue procedures? Systemic rheumatic diseases in the intensive care unit. Z Rheumatol 78(10):955–966
Johnson JP, Moore J, Austin HAI, Balow JE, Antonovych TT, Wilson CB (1985) Therapy of anti glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine 64(4):219–227
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Löffler und B. Hellmich geben an, dass kein Interessenkonflikt besteht.
Additional information
Redaktion
C. Fiehn, Baden Baden
B. Hellmich, Kirchheim-Teck
I. Kötter, Hamburg
K. Krüger, München
Rights and permissions
About this article
Cite this article
Löffler, C., Hellmich, B. PEXIVAS – Der Todesstoß für den Plasmaaustausch bei ANCA-assoziierter Vaskulitis?. Z Rheumatol 79, 910–911 (2020). https://doi.org/10.1007/s00393-020-00895-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-020-00895-z